Sponsor Dossier
Orion Pharma (AUS)
Sponsor Dossier for Orion Pharma (AUS). ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANKSILON
- Brand: BISALAX
- Brand: BUFOMIX EASYHALER
- Brand: CHEXATE
- Brand: DEXDOR
- Brand: ELDEPRYL
- Brand: FARESTON
- Brand: ORIDOPA
About
Orion Pharma (AUS) is an Australian Private Company with ABN 15654099608, registered in NSW and currently active.
Portfolio
Orion Pharma (AUS) has 11 brands on the ARTG, of which 11 are indexable and 11 carry a Product Information document. 8 brands are PBS-listed, 3 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ANKSILON, BISALAX, BUFOMIX EASYHALER, CHEXATE, DEXDOR, ELDEPRYL, FARESTON, ORIDOPA, SALFLUMIX EASYHALER, SANDRENA, TAMOSIN.
Therapeutic focus
— Oncology: 3 brands — Respiratory: 2 brands — Neurology: 2 brands — Gastroenterology: 1 brand — Psychiatry: 1 brand — Reproductive Health: 1 brand — Pain Management: 1 brand
PBS footprint
8 brands are PBS-listed, with the latest PBS schedule date 2026-11-01.
Regulatory activity
The latest PBAC outcome is 2024-07-01, across 3 brands with a PBAC outcome on record.